Thermo Fisher announces mass spectrometry solution to decipher complex mixtures of large macromolecules

By The Science Advisory Board staff writers

June 15, 2022 -- Thermo Fisher Scientific is offering its Direct Mass Technology mode to enable simultaneous charge detection for analysis of previously unmeasurable analytes. The company contends the mass spectrometry solution will provide proteomics and biopharmaceutical laboratories working in drug discovery and R&D applications with the ability to decipher complex mixtures of large macromolecules.

The Direct Mass Technology mode augments Thermo Fisher's Q Exactive Ultra High Magnification Radiography (UHMR) Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities, enabling direct mass determination of hundreds to thousands of individual ions in a single spectrum. With this capability, laboratories will be able to measure mass for complex heterogeneous mixtures of multiple charged components, providing insights into proteoforms, biotherapeutics, and next-generation drug modalities, according to the company.

Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers. Image courtesy of Business Wire.

"Direct Mass Technology mode combines charge detection with our trusted high-resolution accurate mass Orbitrap measurements to achieve results unattainable by current ensemble measurement techniques," said Iain Mylchreest, vice president of research and development, analytical instruments at Thermo Fisher Scientific. "By dissolving the complexity barriers inherent to other approaches, we're enabling a wealth of investigations that were once firmly out of reach -- from resolving heavily modified proteoforms to revealing small changes in large antibody-drug conjugate complexes, to name but a few."

Thermo Fisher and Qatar Genome accelerate precision medicine innovations
Thermo Fisher Scientific and Qatar Genome Program have partnered to promote the development of genomic research tools and clinical applications to expand...
Thermo Fisher and LabShares support biotech startups with equipment
Thermo Fisher Scientific and LabShares Newton have agreed to collaborate in providing resources to early-stage life science companies seeking to grow....
Thermo Fisher releases new qPCR solutions to improve biologics development
Thermo Fisher Scientific has launched a series of QualTrak quantitative polymerase chain reaction (qPCR) biopharma solutions to enhance the drug development...
Thermo Fisher and Charles River join Multiply Labs’ robotic consortium
Multiply Labs has added Thermo Fisher Scientific and Charles River Laboratories to its robotic cell therapy manufacturing consortium, joining Cytiva and...
Portal Innovations partners with Thermo Fisher company
Portal Innovations is collaborating with Life Technologies, part of Thermo Fisher Scientific, to combine Life Technologies’ lab equipment and software...

Copyright © 2022

Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter